476 related articles for article (PubMed ID: 37344450)
1. Human pluripotent stem cell (hPSC) and organoid models of autism: opportunities and limitations.
Kilpatrick S; Irwin C; Singh KK
Transl Psychiatry; 2023 Jun; 13(1):217. PubMed ID: 37344450
[TBL] [Abstract][Full Text] [Related]
2. Modeling Autism Spectrum Disorders with Induced Pluripotent Stem Cell-Derived Brain Organoids.
Santos JLS; Araújo CA; Rocha CAG; Costa-Ferro ZSM; Souza BSF
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830629
[TBL] [Abstract][Full Text] [Related]
3. Modeling Developmental Brain Diseases Using Human Pluripotent Stem Cells-Derived Brain Organoids - Progress and Perspective.
Bhattacharya A; Choi WWY; Muffat J; Li Y
J Mol Biol; 2022 Feb; 434(3):167386. PubMed ID: 34883115
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
Prem S; Millonig JH; DiCicco-Bloom E
Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
[TBL] [Abstract][Full Text] [Related]
5. 3D brain Organoids derived from pluripotent stem cells: promising experimental models for brain development and neurodegenerative disorders.
Lee CT; Bendriem RM; Wu WW; Shen RF
J Biomed Sci; 2017 Aug; 24(1):59. PubMed ID: 28822354
[TBL] [Abstract][Full Text] [Related]
6. Human stem cell-based models for studying autism spectrum disorder-related neuronal dysfunction.
Cheffer A; Flitsch LJ; Krutenko T; Röderer P; Sokhranyaeva L; Iefremova V; Hajo M; Peitz M; Schwarz MK; Brüstle O
Mol Autism; 2020 Dec; 11(1):99. PubMed ID: 33308283
[TBL] [Abstract][Full Text] [Related]
7. Dynamic 3D Combinatorial Generation of hPSC-Derived Neuromesodermal Organoids With Diverse Regional and Cellular Identities.
Whye D; Wood D; Kim KH; Chen C; Makhortova N; Sahin M; Buttermore ED
Curr Protoc; 2022 Oct; 2(10):e568. PubMed ID: 36264199
[TBL] [Abstract][Full Text] [Related]
8. Human Inducible Pluripotent Stem Cells and Autism Spectrum Disorder: Emerging Technologies.
Nestor MW; Phillips AW; Artimovich E; Nestor JE; Hussman JP; Blatt GJ
Autism Res; 2016 May; 9(5):513-35. PubMed ID: 26426199
[TBL] [Abstract][Full Text] [Related]
9. Modeling of Autism Using Organoid Technology.
Choi H; Song J; Park G; Kim J
Mol Neurobiol; 2017 Dec; 54(10):7789-7795. PubMed ID: 27844287
[TBL] [Abstract][Full Text] [Related]
10. Human Pluripotent Stem Cell-Based Models for Hirschsprung Disease: From 2-D Cell to 3-D Organoid Model.
Lui KN; Ngan ES
Cells; 2022 Oct; 11(21):. PubMed ID: 36359824
[TBL] [Abstract][Full Text] [Related]
11. Psychiatry in a Dish: Stem Cells and Brain Organoids Modeling Autism Spectrum Disorders.
Ilieva M; Fex Svenningsen Å; Thorsen M; Michel TM
Biol Psychiatry; 2018 Apr; 83(7):558-568. PubMed ID: 29295738
[TBL] [Abstract][Full Text] [Related]
12. In vitro models for ASD-patient-derived iPSCs and cerebral organoids.
Hohmann SS; Ilieva M; Michel TM
Prog Mol Biol Transl Sci; 2020; 173():355-375. PubMed ID: 32711817
[TBL] [Abstract][Full Text] [Related]
13. Modeling endodermal organ development and diseases using human pluripotent stem cell-derived organoids.
Pan FC; Evans T; Chen S
J Mol Cell Biol; 2020 Aug; 12(8):580-592. PubMed ID: 32652003
[TBL] [Abstract][Full Text] [Related]
14. Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling.
Tian L; Gao J; Garcia IM; Chen HJ; Castaldi A; Chen YW
Wiley Interdiscip Rev Dev Biol; 2021 Nov; 10(6):e399. PubMed ID: 33145915
[TBL] [Abstract][Full Text] [Related]
15. Development of a 3-D Organoid System Using Human Induced Pluripotent Stem Cells to Model Idiopathic Autism.
Lunden JW; Durens M; Nestor J; Niescier RF; Herold K; Brandenburg C; Lin YC; Blatt GJ; Nestor MW
Adv Neurobiol; 2020; 25():259-297. PubMed ID: 32578151
[TBL] [Abstract][Full Text] [Related]
16. Brain organoids: A revolutionary tool for modeling neurological disorders and development of therapeutics.
Acharya P; Choi NY; Shrestha S; Jeong S; Lee MY
Biotechnol Bioeng; 2024 Feb; 121(2):489-506. PubMed ID: 38013504
[TBL] [Abstract][Full Text] [Related]
17. Cultures and cures: neurodiversity and brain organoids.
Barnhart AJ; Dierickx K
BMC Med Ethics; 2021 May; 22(1):61. PubMed ID: 34001098
[TBL] [Abstract][Full Text] [Related]
18. Using iPSC-Based Models to Understand the Signaling and Cellular Phenotypes in Idiopathic Autism and 16p11.2 Derived Neurons.
Turkalj L; Mehta M; Matteson P; Prem S; Williams M; Connacher RJ; DiCicco-Bloom E; Millonig JH
Adv Neurobiol; 2020; 25():79-107. PubMed ID: 32578145
[TBL] [Abstract][Full Text] [Related]
19. iPSC toolbox for understanding and repairing disrupted brain circuits in autism.
Chiola S; Edgar NU; Shcheglovitov A
Mol Psychiatry; 2022 Jan; 27(1):249-258. PubMed ID: 34497379
[TBL] [Abstract][Full Text] [Related]
20. The promises and challenges of human brain organoids as models of neuropsychiatric disease.
Quadrato G; Brown J; Arlotta P
Nat Med; 2016 Nov; 22(11):1220-1228. PubMed ID: 27783065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
